Eric Aguiar, Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 10,000 shares at $45.00 ($450K) on 2019-09-11, disclosed to the SEC on 2019-09-13.
Open-market sale of $450k BHVN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NVTA | SELL | 2020-07-16 | $680K | — | Filing → |
| BHVN | SELL | 2020-01-24 | $114K | — | Filing → |
| BHVN | SELL | 2020-01-10 | $1.7M | — | Filing → |